-

Blackstone Hires Paget MacColl as Global Head of Blackstone Alternative Asset Management’s (BAAM) Institutional Client Solutions

NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE:BX) today announced that Paget MacColl has joined the firm as Global Head of Blackstone Alternative Asset Management’s (BAAM) Institutional Client Solutions. In this role, Ms. MacColl will lead BAAM’s Limited Partner relationships and business development globally, leveraging her nearly 20 years of experience working with investors across alternative investments.

Joe Dowling, Blackstone Global Co-Head of BAAM, said: “As we constantly seek to communicate the tremendous power of BAAM and the Blackstone platform, Paget’s expertise will be invaluable. She brings a strategic perspective which will be critical as we continue to drive innovation and launch new strategies across BAAM.”

John McCormick, Blackstone Global Co-Head of BAAM, said: “Paget is a talented executive with experience marketing the investment solutions that BAAM has to offer to investors around the world. She brings a diverse range of skills, relationships and experiences and will be a critical leader within BAAM and the broader Blackstone ICS team.”

Paget MacColl, Global Head of Institutional Client Solutions for BAAM, said: “I’m thrilled to be joining John and Joe and the incredible team at BAAM. BAAM has been a leader in providing alternative investment strategies to clients for decades and I look forward to continuing that tradition.”

Ms. MacColl joins from Goldman Sachs Asset Management where she was co-head of the Americas Institutional Client Business. In that role, she was responsible for leading business strategy and client engagement with institutions across the US, Canada and Latin America. Prior to that, she led the institutional distribution and fundraising efforts in Asset Management as the Global Head of Institutional Capital Markets. Ms. MacColl joined Goldman Sachs in 1999 as part of its Debt Capital Markets business and was named managing director in 2009 and partner in 2016. She received a BA from Princeton University and is a CFA Charterholder. She serves on the Board of Trustees of Greenwich Academy and The Children’s School.

About Blackstone

Blackstone is one of the world’s leading investment firms. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our $649 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com. Follow Blackstone on Twitter @Blackstone.

Contacts

Media Contact
Paula Chirhart
+1-347-463-5453
paula.chirhart@blackstone.com

Blackstone

NYSE:BX

Release Versions

Contacts

Media Contact
Paula Chirhart
+1-347-463-5453
paula.chirhart@blackstone.com

More News From Blackstone

Blackstone Real Estate Debt Strategies Launches Homebuilder Lending Platform

NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE: BX) today announced that Blackstone Real Estate Debt Strategies (“BREDS”) has launched a lending platform that will provide much needed capital and flexibility to homebuilders, and expects to enable the construction of over 50,000 for-sale homes across the United States annually. This lending platform is supported by BREDS portfolio company, Brio Homebuilder Solutions, as well as partnerships with third parties. This commitment comes at a time when t...

Blackstone Life Sciences Invests $250 Million in Anagram Therapeutics to Advance Novel and Patient-Friendly Oral Enzyme Replacement Therapy for Pancreatic Insufficiency

NEW YORK & NATICK, Mass.--(BUSINESS WIRE)--Blackstone Life Sciences (“BXLS”) today announced a $250 million investment in Anagram Therapeutics (“Anagram”), a clinical-stage private biopharmaceutical company dedicated to improving the lives of people living with exocrine pancreatic insufficiency due to cystic fibrosis (“CF”), pancreatic cancer and related disorders. The investment will help fund the further development, approval and launch of Anagram’s ANG003, a novel orally delivered recombinan...

Anthropic Partners with Blackstone, Hellman & Friedman, and Goldman Sachs to Launch Enterprise AI Services Firm

SAN FRANCISCO--(BUSINESS WIRE)--Anthropic, Blackstone, Hellman & Friedman, and Goldman Sachs today announced the formation of a new AI-native enterprise services firm that will work with companies to rapidly bring Claude into their core business operations. The new firm is a standalone entity with Anthropic engineering and partnership resources embedded directly within its team. Alongside the founding partners, the new company is backed by a consortium of leading alternative asset managers...
Back to Newsroom